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http://dx.doi.org/10.1016/j.ajic.2014.04.008Background: Antibiotics used to reduce nasal colonization by Staphylococcus aureus in patients before
admission are inappropriate for carriage reduction on a regular basis within a hospital community.
Effective nonantibiotic alternatives for daily use in the nares will allow reduction of this bacterial source
to be addressed.
Methods: Our study tested the effectiveness of a nonantibiotic, alcohol-based antiseptic in reducing nasal
bacterial carriage in health care professionals (HCPs) at an urban hospital center. HCPs testing positive for
vestibular S aureus colonization were treated 3 times during the day with topical antiseptic or control
preparations. Nasal S aureus and total bacterial colonization levels were determined before and at the
end of a 10-hour workday.
Results: Seventy-eight of 387 HCPs screened (20.2%) tested positive for S aureus infection. Of 39 subjects
who tested positive for S aureus infection who completed the study, 20 received antiseptic and 19
received placebo treatment. Antiseptic treatment reduced S aureus colony forming units from baseline by
99% (median) and 82% (mean) (P < .001). Total bacterial colony forming units were reduced by 91%
(median) and 71% (mean) (P < .001).
Conclusions: Nasal application of a nonantibiotic, alcohol-based antiseptic was effective in reducing
S aureus and total bacterial carriage, suggesting the usefulness of this approach as a safe, effective, and
convenient alternative to antibiotic treatment.
Copyright  2014 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. Open access under CC BY-NC-ND license.Although estimates vary, studies indicate that between 20% and
40% of healthy individuals within the continental United States
exhibit nasal vestibular carriage of Staphylococcus aureus.1 All in-
dividuals within health care environments in whom subclinical
nasal carriage of S aureus and other potentially pathogenic bacteria
is present contribute to the burden of infection risk to themselves
and others. Nasal colonization is known to be predominantly
localized in the anterior, vestibular region of the nasal anatomy.2D, MA, CPI, Department of
e Ave, MSC 550, Charleston,
and, funded this study and
data collection, analysis, orData support the premise that individuals exhibiting subclinical
nasal colonization by S aureus can be grouped into persistent,
intermittent, and noncarrier types.3-5 In a study using artiﬁcial
inoculation, carriage characteristics were similar in intermittent
carrier and noncarriers (comprising 76% of the total), but distinct
from those of the persistent carrier group.6 These ﬁndings are
consistent with the concept that either most individuals are actu-
ally intermittent carriers or are noncarriers who exhibit carriage
only under environmental pressure (eg, recurring exposure).6 In
either instance, the demonstrated ability of these 2 groups to sus-
tain transient subclinical carriage for 4-14 days on average would
put either of them in a position to increase risk for S aureus infec-
tion in themselves or others with whom they come in contact
during that period.
Within the health care community, there are several categories
of individuals who maintain a long-term presence within thatOpen access under CC BY-NC-ND license.
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but who may contribute to its presence. These include longer-term
patients as well as health care professionals (HCPs) and support
staff who regularly come in contact with patients. In a study of 256
HCPs at a large urban tertiary care teaching hospital,7 including
paramedics, nurses, clerical workers, and physicians, S aureus was
isolated from the anterior nares of 43.8% of those screened
with 6.6% exhibiting methicillin-resistant S aureus (MRSA) carriage.
The authors point to 3 potential consequences of this carriage: self-
infection of these workers by their own strains, cross-transmission
to patients, and introduction of the pathogen into their commu-
nities.7 Furthermore, a study using whole-genome sequencing to
investigate MRSA transmission within a neonatal intensive care
unit provided evidence of the complexity of transmission that can
occur in both directions involving patients and caregivers.8
Strategies to reduce colonization in patients preadmission have
been shown to be very successful. These have primarily focused on
regimens that include nasal treatment with the antibiotic mupir-
ocin.9-12 Recently, a multicenter study suggested the potential
utility of universal antibiotic treatment of patients at admission
without screening for speciﬁc carriage to be an effective approach
to reduce intensive care unit MRSA infections.13 Although effective,
strategies that incorporate wide use of antibiotics lead to increased
opportunities for the development of resistant bacteria. For this
reason, nasal antibiotics are typically not used on a regular basis to
reduce subclinical colonization in individuals within the health
care environment in whom prophylactic treatment might be
beneﬁcial. These could include patients with immune deﬁciency or
who are otherwise at higher-risk for infection and longer-term
patients, as well as HCPs and other staff who work in the patient
environment.
The development of effective and convenient nonantibiotic
nasal preparations for daily use could provide appropriate addi-
tional methods for infection control, addressing the well-known
hand-to-nose-to-hand cycle of inoculation and contamination
involving the nasal bacterial repository.14 A nonselective antiseptic
agent, such as ethanol, would be expected to reduce colonization by
all strains of bacteria, similar to a broad-spectrum antibiotic, but
with both gram-positive and gram-negative bacteria being affected
and without the risk of resistance being developed. In patients,
daily application of such an agent could reduce the risk of self-
inoculation and contamination of the hospital room environment.
The regular use of a nasal antiseptic by HCPs could reduce their
involvement in the process of bacterial transference, as well as
contribute to their own preventive and protective hygiene in the
work environment.
The goal of our study was to determine the magnitude and
breadth of bacterial reduction by a nonantibiotic, alcohol-based
nasal antiseptic applied during a typical workday in primary
HCPs. Study subjects included nurses and surgical technicians
directly participating in patient treatment and care on the day of
testing. Data were collected on the treatment effects on both
S aureus and total bacterial carriage in the nasal vestibule during a
single day of application.METHODS
Selection and enrollment of study subjects
Volunteers were recruited from the nursing and technical staff
working in the main and ambulatory operating rooms and patient
care ﬂoors of theMedical University of South Carolina Hospital. This
randomized double-blind, placebo-controlled study was approved
by the Medical University of South Carolina Institutional ReviewBoard (Pro000018198). This study is registered on clinicaltrials.gov
(Identiﬁer: NCT01861457).
Eligible to participate were healthy HCPs between ages 18 and
70 years who were able and agreed to refrain from using all nasal
spray preparations or washes from the time of their screening
through their scheduled study day. Exclusionary criteria included
symptoms of upper respiratory disease, including chronic rhinitis/
sinusitis, seasonal allergies, upper respiratory infection during the
previous 4 weeks; the use of antibiotics in the 2 weeks before or
during the study; a known allergy to citrus oil; or being a cigarette
smoker. Nonsmokers were deﬁned as those individuals who had
abstained from smoking for at least 1 year before the study.
After obtaining informed consent, eligible subjects were
screened by nasal swab for vestibular carriage of S aureus as
described below. Subjects who screened positive and who accepted
enrollment in the study were scheduled for participation within 10
days to minimize loss of carriage status by the study date.
Study protocol
The study period consisted of a single 10-hour workday, during
which nasal swab samples from the right and left nasal vestibules
of each subject were obtained and pooled (Fig 1). The ﬁrst com-
bined sample from each subject was collected by the medical study
staff at the start of the workday (hour 0), immediately followed by
application of the randomly assigned placebo or test preparation
with a saturated swab to both nasal vestibules. Application of the
placebo preparation was used to control for the potential me-
chanical effects of the application process, itself. Reapplications of
the placebo and treatment preparations were made at hours 4 and
8. At hour 10, the subjects returned to enable collection of the
posttreatment nasal sample by the medical study staff.
Preparation and application of the test and control agents
A commercially available, nonprescription product, Nozin Nasal
Sanitizer antiseptic (Global Life Technologies Corp, Chevy Chase,
Md) was used as the test agent in our study. The safety-tested
formulation is composed of 70% ethanol active combined with a
mixture of natural oil emollients and the preservative benzalkonium
chloride. Sterile phosphate-buffered saline with 0.017% peppermint
oil as a masking agent was used as placebo treatment control.
Application of the antiseptic or placebo control preparationwas
made by saturating a sterile swab with 5 drops (w200 uL) of so-
lution and rotating the swab around the inside of the vestibular
surfaces of both nostrils.
Sample collection and analysis
Nasal samples from both screening and study sample collection
were obtained using sterile BD ESwab Collection Kits (Becton,
Dickenson & Co, Franklin Lakes, NJ). For screening, neat samples
were inoculated onto BBL CHROMagar Staph aureus medium
(Becton, Dickenson & Co) and incubated at 35C for 24 hours;
mauve colonies were identiﬁed as S aureus by Gram’s stain, cata-
lase, and latex agglutination testing. For evaluation of treatment
samples, duplicate 75 mL aliquots of neat and 1:10 dilutions of each
sample were inoculated onto plates of BBL CHROMagar Staph
aureus medium and tryptic soy agar with 5% sheep blood to assess
S aureus and total bacterial colony forming units (CFU) counts,
respectively. At 24 hours of incubation at 35C, CHROMagar plates
were photographed and mauve colonies were counted and iden-
tiﬁed as S aureus as described above. At 48 hours of incubation at
35C, tryptic soy agar plates were photographed for determination
of total bacterial CFU. All data from subjects whose baseline inocula
Table 1
Characteristics of the screened health care provider study participants
Fig 1. Schematic of the study protocol. Three applications of placebo or antiseptic preparation were made at 4-hour intervals during the workday to both nasal vestibules of subjects
randomly assigned to 1 of the 2 treatment groups. Combined nasal swab samples from both vestibules were collected before and after treatment, at 0 hours and 10 hours, to assess
changes in nasal vestibular Staphylococcus aureus (S aureus) colonization and total bacterial colony forming units (CFU) counts.
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were excluded from analysis.Characteristic n (%)
Staphylococcus aureus positive
n (%) OR (95% CI)* Py
Mean age, y 40.8
Total screened 387 (100) 78 (20.2)
Female 329 (85.0) 65 (19.8) Ref -
Male 58 (15.0) 13 (22.4) 1.17 (0.60-2.3) .77
Position title
RN 179 (46.3) 47 (26.3) Ref -
PCT/ORA 50 (12.9) 8 (16.0) 0.54 (0.23-1.22) .19
MD/PA/NP/CRNA 35 (9.0) 7 (20.0) 0.70 (0.29-1.71) .57
Other 123 (31.8) 16 (13.0) 0.42 (0.23-0.78) .01
Work location
Floors 212 (54.8) 41 (19.3) Ref -
Operating room 112 (28.9) 24 (21.4) 1.14 (0.65-2.00) .76
Other 62 (16.0) 13 (21.0) 1.11 (0.55-2.23) .92
Children aged 6 mo-11 y 102 (26.4) 20 (19.6) 0.96 (0.54-1.68) .99
Dog(s) 180 (46.5) 37 (20.6) 1.05 (0.64-1.72) .96
Cat(s) 67 (17.3) 15 (22.4) 1.18 (0.62-2.23) .74
CI, conﬁdence interval; CRNA, certiﬁed registered nurse anesthetist; MD, physician;
NP, nurse practitioner; OR, odds ratio; ORA, operating room assistant; PA, physician
assistant; PCT, patient care technician; Ref, reference group; RN, registered nurse.
*Calculated using the indicated reference group and comparing the S aureus-
positive population with the S aureus-negative population.
yCalculated using the indicated reference group or the corresponding negative
characteristic group and comparing the S aureus-positive population to the
S aureus-negative population. The c2 test was used.Data handling and analysis
S aureus and total bacterial CFU counts for analysis were derived
from pairs of plates on which identical 75 m aliquots of neat or 1:10
dilutions of each nasal sample were cultured. Whenever colony
densities allowed, CFU counts from the pair of neat pre- and
posttreatment plates were used. In the event that neat colony
densities were too high to allow accurate counting, the pair of 1:10
dilution plates for that subject was used and the CFU counts were
multiplied by 10 to arrive at a “neat” equivalent value. In no
instance was a comparison made between neat and diluted sam-
ples from a subject in the analysis of pre- to posttreatment values.
CFU counts were made by 2 independent, blinded readers using
photographs of the cultures and the average values were used.
All data analyses were performed with Medcalc 12.6.1.0 (Med-
Calc Software, Ostend, Belgium) and Sigma Stat 3.5 and SigmaPlot
11.2 (Systat Software, Inc, Chicago, Ill). Comparisons of baseline
subject characteristics and clinical outcomes and their odds ratios
were based on c2 analyses with Yates continuity correction applied.
Comparisons of the nonnormally distributed median values from
different groups and from study treatment effects were analyzed by
the Mann-Whitney rank sum test and the Wilcoxon signed rank
test, respectively. The Pearson correlation was used to determine
the relationship of carriage reduction by the antiseptic on S aureus
and total bacterial strains. A k analysis was used to conﬁrm that
there was adequate strength of agreement between the 2 inde-
pendent CFU counts for each cultured sample that were averaged
for use as outcome variables (mean weighted k ¼ 0.951). A P value
< .05 was considered indicative of statistical signiﬁcance.RESULTS
Demographic factors in S aureus carriage
Table 1 summarizes the characteristics of the 387 HCPs who
were screened for the presence of nasal S aureus colonization. Thepopulation was predominantly female (85%) and composed of 66%
white, 27% African American, 4% Asian, and 3% “other” subjects. Of
the screened population, 20.2% tested positive for S aureus carriage.
Workers were classiﬁed by their position title and worksite loca-
tion. The presence of 1 or more children between ages 6 months
and 11 years and dogs and cats at home were determined as po-
tential contributors to colonization risk. Registered nurses tended
to exhibit higher carriage prevalence than staff in other positions
(26.3%). A peripheral ﬁnding was that African American women
who were screened were signiﬁcantly less likely to be colonized
than white women (12.6% vs 23.7%, respectively; odds ratio, 0.466
[95% conﬁdence interval, 0.24-0.91]; P ¼ .03). There were no other
factors observed to be associated with the prevalence of S aureus
carriage in the screened population.
Table 2
Comparison of characteristics of treatment groups in health care provides testing
positive for Staphylococcus aureus infection
Characteristic Placebo Antiseptic
Total subjects 19 20
Mean age 35.4 (26-67) 34.5 (26-64)
Baseline colonization
S aureus 562  1,113 756  1,512
All strains* 1,289  1718 1,200  1,694
Female 14 20
Male 5 0
Occupation
RN 10 15
PCT/ORA 1 2
MD/PA/NP/CRNA 5 0
Other 3 3
Location
Floors 14 14
Operating room 1 4
Other 4 2
NOTE. Values are presented as n, y (range), or colony forming units  standard
deviation.
CRNA, certiﬁed registered nurse anesthetist; MD, physician; NP, nurse practitioner;
ORA, operating room assistant; PA, physician assistant; PCT, patient care technician;
RN, registered nurse.
*As determined by growth on tryptic soy agar plates (5% sheep blood).
Fig 2. Nasal vestibular bacterial colonization in baseline (PRE) and posttreatment
(POST) samples. Numbers of colony forming units in identical samples plated onto
CHROMagar SA (Becton, Dickenson & Co, Franklin Lakes, NJ) and tryptic soy agar blood
agar plates for assessment of Staphylococcus aureus and total bacterial colonization
before and after treatment, as described in detail in the Methods section. *No signif-
icant difference from the baseline value in the corresponding placebo-treated group.
ySigniﬁcantly different (P < .001) from the PRE value.
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The characteristics of the 39 subjects who tested positive for
S aureus infection who were randomly assigned to the placebo
and antiseptic-treatment groups are shown in Table 2. The 2
groups were statistically indistinguishable with regard to
participant average ages or their baseline levels of colonization by
either S aureus (P ¼ .633) or total bacterial strains (P ¼ .790).
Consistent with the characteristics of the total screened pool
from which the S aureus-colonized subjects were drawn, the
treatment study groups were predominantly women and regis-
tered nurses.Fig 3. Comparison of the effects of placebo and antiseptic application procedures on
bacterial colonization during the 10-h study period. Mean percent changes in bacterial
carriage resulting from the process of applying phosphate buffered saline versus an
active antiseptic. *Signiﬁcantly different (P < .001) from Staphylococcus aureus in the
placebo-treated subjects. ySigniﬁcantly different (P < .001) from total bacterial proﬁle
in the placebo-treated subjects.Reduction in S aureus and total bacterial carriage
As shown in Figure 2, there was substantial between-subject
variation in baseline levels of both S aureus-speciﬁc and total
bacterial strain colonization. This variation was similar in both
control (placebo) and test (antiseptic) groups. Comparison of the
baseline level of S aureus to total bacterial carriage in both
groups indicates that, on average, S aureus accounted for
approximately half of the total vestibular bacterial load in this
study population.
Three applications of the antiseptic at 4-hour intervals during the
course of the workday signiﬁcantly reduced the mean  standard
error number of S aureus colonies from 756 338 at baseline to 30
12 at the end of the 10-hour study period (Fig 2). Although 19 of 20
subjects demonstrated a reduction in carriage, 10 subjects showed a
100% decrease with an additional 3 subjects who showed >95%
decrease. A similarly pronounced and signiﬁcantly signiﬁcant
responsewas seen in total bacterial CFUs, with a reduction of 1,200
379 CFU to 167  70 CFU (Fig 2). The observed reduction in carriage
was >90% in 12 subjects, including 4 subjects at 100%.
In marked contrast, the placebo treatment application process
resulted in a substantial mean increase in S aureus colony counts
from 562  255 CFU to 1,239  838 CFU. This increase was not
statistically signiﬁcant due to the >3-fold increase in variability of
the colonization response (increase in standard deviation of the
mean from 1,113 to 3,651 CFU) that accompanied the effect. A
similar placebo-induced change from baseline in total bacterialCFUs was also not statistically signiﬁcant. These data are consistent
with the notion that the disruption of the relatively stable vestib-
ular colonization caused by the mechanical disturbance of the
application process itself may stimulate bacterial growth in the
anterior nares in certain individuals if an effective antimicrobial
agent is not present to inhibit it.
The effects of placebo and antiseptic treatments on bacterial
nasal carriage expressed as percent change from baseline are
shown in Figure 3. Antiseptic treatment produced a uniform
reduction in CFUs at a level of 82% (mean) and 99% (median) for
S aureus and 71% (mean) and 91% (median) for total bacteria.
These reductions were signiﬁcantly different from corresponding
placebo-related effects, despite the wide variance displayed in the
latter data. In contrast, the near 100% mean increase observed in
S aureus colonization in the placebo-treated group was not statis-
tically signiﬁcant from baseline due to that variance.
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The broad-spectrum, nonselective characteristics of the
ethanol-based antiseptic preparation were assessed by evaluating
the correlation between its antibacterial effectiveness in reducing
S aureus colonization and total bacterial colonization in individual
subjects. Comparison of individual values for the pair was based on
CFU counts made on the same sample. The mean and median
percent reductions in colonization of the 2 bacterial target groups
fell within 11% and 8% of each other, respectively, and the statisti-
cally signiﬁcant Pearson correlation coefﬁcient value for these data
from all antiseptic-treated subjects was 0.827 (P< .001). These data
are consistent with a comparable effectiveness of the antiseptic
preparation in reducing nasal carriage of these 2 bacterial target
groups.DISCUSSION
The need for a screening process to identify subjects who were
S aureus-colonized enabled the characterization of the population
of 387 HCPs fromwhich the antiseptic treatment study participants
were drawn. The 20.2% prevalence of S aureus carriage in our study
population fell at the lower end of the wide spectrum reported for
HCPs, which may range from 20%-40% or higher depending on the
facility and nature of the workforce.1,7,15 Some data suggest that
carriage in female HCPs can be lower than that in male HCPs and
that may have been a contributing factor to low carriage in our
predominantly female screening population.15,16 The small pro-
portion of men in our screened population (58 men, 15% of those
screened) likely provided insufﬁcient power to identify a signiﬁcant
effect of sex on carriage prevalence.
One potential concern for the use of alcohol- or other antiseptic
agent-based preparations in the nasal vestibule is dryness, irrita-
tion, or other discomfort associated with its repeated use. A
formulation designed to address this concern by incorporating
moisturizing constituents, such as the natural oil mix of the test
preparation used in our study, is essential. There were no reports of
these or other adverse consequences made during the exit inter-
view by the participants in the multitreatment protocol. Although
the preparation used in our study has been available as an over-the-
counter product for the past 6 years, the short-term nature of our
study does not address the question of potential adverse effects
over time, nor does it provide insight into the potential positive
cumulative effectiveness of the preparation in reducing carriage
when used in a multiday regimen.
Three applications of the alcohol-based antiseptic preparation
during the course of a single workday resulted in a pronounced
reduction in nasal vestibular carriage of both S aureus and other
cultivable bacteria. In general, reductions were very consistent
across subjects, with a median decrease in the antiseptic-treated
group of 98.8% at the end of the 10-hour workday. The design of
our study did not allow assessment of the rate of bacterial killing
during the study period. However, a surgical scrub study showed
that the bactericidal activity of 70% ethanol in the presence of
emollients, as was the case in the test preparation, resulted in near-
maximum activity within minutes of application.17 If applicable to
our study, nasal decolonization may also have been demonstrable
in the study subjects at times before collection of the end-of-day
sample.
There is no obvious explanation for the 1 of 20 subjects in the
treatment group who did not demonstrate decolonization. Because
that response was unique to that subject and was seen in both
S aureus and total bacterial CFU counts, it might be that the
outcome resulted from a procedural error in application orsampling or that there was an unreported modiﬁcation to the nasal
environment by the subject during the study day.
Application of the phosphate-buffered saline placebo unex-
pectedly led to dramatic shifts in colonization. Because the appli-
cation process was identical in control and antiseptic-treated
subjects, it is reasonable to assume that the same effect was pro-
duced in both treatment groups. An interesting possibility is that
the mechanical process of swabbing can lead to disruption of a
stable bacterial environment in some individuals leading to stim-
ulated growth in the absence of a deterring antibacterial agent.
Whatever its cause, this effect was completely eliminated in the
antiseptic-treated subjects, further supporting the effectiveness of
the alcohol-based preparation in achieving carriage reduction.
The observation of highly correlated and statistically signiﬁ-
cant reductions in S aureus and total bacterial CFU counts is
consistent with the notion that the antiseptic exhibited broad
efﬁcacy against the range of bacteria colonizing the nasal vesti-
bule. Further studies following a similar design and using 16S
ribosomal RNA analysis to determine effects on the range of
bacterial taxa within a given individual18 will be needed to verify
the consistency of antibacterial reduction across the constituent
bacterial ﬂora.CONCLUSIONS
The results of our unique study demonstrate the effectiveness
of single-day, alcohol-based nasal antiseptic treatment in
reducing vestibular colonization by S aureus and other poten-
tially pathogenic bacteria in HCPs. The HCPs selected for our
study represent 1 of several populations within the health care
environment, along with chronic-care patients and support staff,
whose long-term presence contributes to the bacterial burden
and associated risk of hospital-acquired infection in themselves
and others. It is likely that a large, multicenter study will be
necessary to establish the evidential basis for the effect of nasal
antiseptic use in contributing to reduction of infection outcomes
in health care settings. Given the multifaceted nature of the
sources likely contributing to the overall bacterial burden and
residual infection rates within most health care environments,
such multicenter studies could be designed to address carriage
by patients, HCPs, or both in combination. Data preliminary to
larger-scale studies might be provided by investigations focused
on currently nondecolonized patients and HCPs at facilities,
perhaps long-term, where prevalence of staph infections are
especially high. It may also be possible that data in support of the
effectiveness of nonantibiotic nasal antiseptic use will result as a
consequence of its adoption by proactive health care facilities, as
was the case with the initial adoption of alcohol-based hand
sanitizer use by HCPs.19 Within the patient population, incor-
porating the use of this antiseptic approach, in conjunction with
the use of hand sanitizers and body wipes, may provide an
important adjunct or alternative to preventive antibiotic therapy
surrounding surgical and medical procedures. Further, because it
will not contribute to bacterial resistance, the ethanol-based
antiseptic provides a unique opportunity for regular daily use
over prolonged periods by patients and staff in long-term care
environments.Acknowledgments
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